Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Revised US HIV treatment guidelines call for a return to "hit hard, hit early"

This article was originally published in Scrip

Executive Summary

A panel of experts from the US Department of Health and Human Services (DHHS) has released revised guidelines recommending that people with HIV start antiretroviral therapy (ART) at CD4 cell counts between 350 and 500 cells/mm3, with some even recommending treatment for patients with CD4 counts greater than 500 cells/mm3. AIDS groups welcomed the change, touting it as a shift back toward the "hit hard, hit early" ART approach that prevailed in the late 1990s.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts